Foundation Medicine Raises More Funds in Series A Round | GenomeWeb
Home » Foundation Medicine Raises More Funds in Series A Round

Foundation Medicine Raises More Funds in Series A Round

Oct 18, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Foundation Medicine today said that it has raised more funds in a Series A round of private financing, bringing the total raised in the round to $33.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Mar 14, 2016

Cambridge Epigenetix Closes $21M Financing Round

Jan 19, 2016

Twist Bioscience Closes $61M Series D Round, Secures $20M Debt Facility

Oct 14, 2015

23andMe Raises $115M in Series E Financing Round

May 16, 2016

Caribou Biosciences Raises $30M in Series B Funding

Aug 29, 2016

Mitra Biotech Closes $27.4M Series B Round

Mar 16, 2016

Pharmacogenomics Firm Prenetics Raises $10M

The Scan

This Week in Science

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

Science in Coach

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Funny Side of Science

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

When the FDA Plays Hardball

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."

What's Popular?

In Clinical & Translational

  1. Study Shows Natera's NIPT Can ID Unrecognized Twins, Fetal Triploidy; May Lower False Positive Rate

  2. Belgium's Walloon Region Funds $2.2M to Explore Role of DNA Hydroxymethylation in Breast Cancer

  3. Cepheid Joins Attack on Roche PCR Patents with Lawsuit; Roche Expects Arbitration to Play Out

    Premium

  4. Study Highlights High False Positive Rate of NIPT for Some Disorders Despite High Specificity

    Premium

  5. Belgium's Multiplicom Raises $2.9M to Pursue CE Mark for Breast Cancer, CF Tests

    Premium

Sponsorships

Privacy Policy.  Copyright © 2016 Genomeweb LLC.  All Rights Reserved.